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Further evidence for  
microtubule-independent 
dimerization of TPPP/p25
J. Oláh, T. Szénási, S. Szunyogh, A. Szabó, A. Lehotzky & J. Ovádi
Tubulin Polymerization Promoting Protein (TPPP/p25) is a brain-specific disordered protein that 
modulates the dynamics and stability of the microtubule network by its assembly promoting, cross-
linking and acetylation enhancing activities. In normal brain it is expressed primarily in differentiated 
oligodendrocytes; however, at pathological conditions it is enriched in inclusions of both neurons and 
oligodendrocytes characteristic for Parkinson’s disease and multiple system atrophy, respectively. The 
objective of this paper is to highlight a critical point of a recently published Skoufias’s paper in which 
the crucial role of the microtubules in TPPP/p25 dimerization leading to microtubule bundling was 
suggested. However, our previous and present data provide evidence for the microtubule-independent 
dimerization of TPPP/p25 and its stabilization by disulphide bridges. In addition, our bimolecular 
fluorescence complementation experiments revealed the dimerization ability of both the full length 
and the terminal-free (CORE) TPPP/p25 forms, however, while TPPP/p25 aligned along the bundled 
microtubule network, the associated CORE segments distributed mostly homogeneously within the 
cytosol. Now, we identified a molecular model from the possible ones suggested in the Skoufias’s 
paper that could be responsible for stabilization of the microtubule network in the course of the 
oligodendrocyte differentiation, consequently in the constitution of the myelin sheath.
Recently in Scientific Reports, Skoufias and co-workers published a paper entitled “Self protein-protein interactions 
are involved in TPPP/p25 mediated microtubule bundling” in which a number of data are presented on the inter-
action of Tubulin Polymerization Promoting Protein (TPPP/p25) forms with tubulin and microtubule (MT)1. In 
our previous studies following the discovery of TPPP/p25 as a microtubule associated protein (MAP) our data 
support a model for TPPP/p25-induced MT bundling2–5. Our reported findings in relation to the structure and 
function of TPPP/p25 - relevant to the Skoufias’s paper1 - are as follows: i) it is a disordered protein with unstruc-
tured N- and C-termini straddling a flexible CORE region as detected by multinuclear magnetic resonance spec-
troscopy6; ii) its dimers display higher tubulin assembly activity than the monomers4; ii) it induces MT assembly 
coupled with bundling activity resulting in resistance against anti-MT agents7. These findings indirectly support 
a mechanism for the stabilization of the MT network by dimeric TPPP/p25.
The objective of this Comment paper is to highlight a critical point leading the authors to the suggestion 
as follows: “the central folded domain of TPPP/p25 following binding to microtubules can drive homotypic 
protein-protein interactions leading to bundled microtubules” (cf. Abstract)1. In fact, this hypothesis is based upon 
the observation that: “Our biophysical analysis of all the fragments though did not support the formation of TPPP/
p25 dimers in solution” (page 11). Our biochemical, biophysical and immunological Please change analysis to 
analyses. have provided evidence for concentration-dependent dimerization of TPPP/p25 in the absence of MTs4, 
however, it is promoted by the presence of ligands such as GTP4 and the bivalent zinc ion8. We have also estab-
lished the role of intermolecular disulphide bridges in the stabilization of the dimers4, and that in the presence of 
dithioerythritol (DTE) (its epimer, DTT was used in the commented paper) the detection of the dimer forms is 
ambiguous4,8. In the experiments presented in Skoufias’s paper1, DTT (1 mM) is present in the TPPP/p25 solu-
tions including the stored stock solutions and the solutions used for the binding and polymerization assays. This 
condition favours neither the detection of the dimeric form nor the dimer-enhanced tubulin polymerization 
activity resulting in low polymerization potency (cf. Fig. 1C of ref. 1 versus Fig. 3B of ref. 5). In order to enhance 
the relative amount of the disulphide-stabilized dimers, in selected experiments the stock solutions of TPPP/p25 
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(200 μ M) were pre-incubated at room temperature, and the dimers could be detected even by sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (cf. Fig. 1) as demonstrated earlier4.
In addition, we detected the dimeric form by other approaches as well such as sandwich enzyme-linked immu-
nosorbent assay (ELISA)8, size exclusion gel chromatography4 and isothermal titration calorimetry4. Now we have 
performed sandwich ELISA experiment with the N- and/or C-terminal free forms as earlier with the full length 
protein to establish the role of the unstructured terminal segments in the dimerization of the TPPP/p25. To vali-
date the in vitro data obtained with isolated protein variants, we have performed in vivo experiments as well using 
bimolecular fluorescence complementation assay (mVenus BiFC), similarly as described in the commented paper1.
Results
Effect of truncation of TPPP/p25 on its dimerization. Our sandwich ELISA assay using mouse mono-
clonal TPPP/p25 antibody9 (mAb) labelled with and without biotin exclusively detects dimeric/oligomeric forms 
of TPPP/p25 in solution independently whether they are stabilized by disulphide bridges or not8.
Figure 1a shows a typical dissociation curve of the full length (FL) TPPP/p25 in the absence and presence of 
the reducing agent DTE. The finding is that the amount of the dimeric forms without reducing agent is much 
higher than with added DTE. Obviously, a fraction of the dimers stabilized by disulphide bridges in the stock 
solution does not dissociate into monomers.
Figure 1. Effect of the truncation of TPPP/p25 on its dimerization. (a) Representative sandwich ELISA 
experiment with TPPP/p25 as presented previously8. Briefly, TPPP/p25 at different concentrations without 
or with preincubation with DTE was added onto the plate coated with mAb9; then the plate was sequentially 
incubated with biotinylated mAb and peroxidase conjugated avidin. (b) A representative image illustrating the 
formation of disulphide-stabilized dimers as detected by SDS-PAGE in the absence of DTE. MM: molecular 
weight marker. 5 μ g protein from the stock solution (200 μ M) were loaded into the gel in the absence of DTE. 
(c) Relative amount of the dimers obtained by sandwich ELISA (cf. Fig. 1a) with (light grey column) or without 
(black column) DTE. Different TPPP forms at 1 μ M concentration were added to the plate coated with mAb in 
the absence and presence of DTE. (d) Dimerization of the different TPPP/p25 forms with full length (FL, grey 
column) or double truncated (CORE, white column) TPPP/p25 tested by sandwich ELISA. 1 μ M FL TPPP/
p25 or CORE TPPP/p25 was preincubated with 100 μ M DTE; then the different TPPP/p25 forms were added, 
and dimers were detected by biotinylated mAb. (a–d) FL full length TPPP/p25, Δ N N-truncated TPPP/p25, Δ 
C C-truncated TPPP/p25, CORE double truncated TPPP/p25. Each data point represents the mean ± SD from 
three independent experiments (a,c,d).
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To obtain information about the ratio of the stabilized dimers and monomers, aliquots from the stock solu-
tions (200 μ M) were loaded directly into SDS-PAGE. As shown in Fig. 1b, substantial fraction of all TPPP/p25 
solutions contains disulphide-stabilized dimers. The stock solutions of the FL and the different truncated forms 
diluted to 1 μ M were applied for sandwich ELISA experiments according to the following experimental design as 
illustrated schematically, the result are presented in Fig. 1c,d:
(c) mAb + TPPP/p25 forms + mAb (black column)
(c) mAb + TPPP/p25 forms + DTE + mAb (light grey column)
(d) mAb + reduced FL + TPPP/p25 forms + mAb (grey column)
(d) mAb + reduced CORE + TPPP/p25 forms + mAb (white column)
In one set of sandwich ELISA experiments the FL TPPP/p25 and its truncated forms were added to the immo-
bilized mAb, and the dimer forms were quantified by biotinylated mAb (Fig. 1c). In the second set of experiments 
reduced FL or CORE form were added to the immobilized mAb, then the associations of the different TPPP/p25 
forms with the monomeric FL or CORE forms were tested by the biotinylated mAb (Fig. 1d).
The sandwich ELISA data presented in Fig. 1c,d demonstrate the dimerization/oligomerization potency of 
all TPPP/p25 forms including the double truncated (CORE) one; in addition, the capability of both the reduced 
(monomer) FL and CORE forms to interact with the various TPPP/p25 forms, even if to different extents, is val-
idated. This issue occurred in the absence of tubulin/MTs.
Effect of TPPP/p25 truncation on the interaction with tubulin and MT. Now turbidity and pellet-
ing measurements were performed with tubulin or paclitaxel-stabilized MTs using FL and N- and/or C-terminal 
truncated forms of TPPP/p25. In fact, similar types of experiments were carried out previously with tubulin5.
As shown in Fig. 2, the polymerization potency of the FL TPPP/p25 to both tubulin and MT is affected by the 
nature of the truncation. According to the Skoufias’s paper the order of the binding constants are published for the 
interaction of the MT with FL, N- or C-terminal free forms (cf. Fig. 4 in ref. 1)1. However, it needs to emphasise 
that there is a difference between the length of the CORE segments 50–157 vs 44–174, used in the two labs, con-
sequently the lengths of the termini are shorter in our case. Nevertheless, the data presented in Fig. 2 qualitatively 
do not differ from that presented in the commented paper. According to our studies, the following qualitative 
order could be established for the binding and polymerization potencies of the TPPP/p25 forms:
Binding potency of TPPP/p25 forms to tubulin FL ~ΔN >ΔC >CORE
Tubulin polymerization promoting potency FL >ΔN >ΔC >>CORE
MT binding potency of TPPP/p25 forms to MT FL ~ΔN >ΔC >CORE
MT bundling potency of TPPP/p25 forms to MT FL ≫ΔN ~ΔC ≫CORE
Intracellular dimerization of TPPP/p25 and its CORE segments. As we revealed earlier TPPP/p25 
co-localizes with the MT network and displays extensive bundling activity in different cell lines expressed by 
transfection (HeLa) or doxycycline induction (CHO10) or endogenously (CG-4), and it regulates the dynamics 
and organization of the MT network via its tubulin polymerization promoting and MT bundling activity as well 
as tubulin acetylation enhancing activity5,7,10. We have also shown with immunofluorescence microscopy that in 
contrast to the FL TPPP/p25 the CORE segment (double truncated form) distributed homogeneously within the 
cytoplasm5. Most importantly, we suggested that “The finding that the double truncated TPPP/p25 cannot associate 
with the MT network underlines the role of the unstructured termini in the physiological function of TPPP/p25” 5.
We have performed a similar set of experiments using BiFC assay (mVenus 1–173 and 155–238 constructs) as 
described in the commented paper1 using mVenus vectors (cf. Fig. 3. legend) to test the associations of the FL-FL 
and CORE-CORE pairs at cellular level as well. As shown in Fig. 3a,b, the assembly of the mVenus pair (green 
fluorescence signal) is visible in both cases that correspond to the in vitro data (cf. Fig. 1). We have performed 
control experiments with the empty mVenus pair (Fig. 3c) in order to distinguish the BiFC signal produced by 
the TPPP/p25 forms from the non-specific BiFC signal generated by the intrinsic tendency of the two fluorescent 
protein domains to complement each other. In this control experiment low fluorescent signal could be detected 
as compared to that performed with the FL or CORE pairs. However, the intracellular localization of the BiFC 
signals was very distinct: in the case of FL protein it is aligned along the bundled MT network (Fig. 3d–f); while, 
the CORE segment-derived signal distributes predominantly homogeneously within the intracellular space of 
HeLa cells (Fig. 3g–i). These in vivo data suggest the involvement of the unstructured termini of TPPP/p25 in 
the cross-linking of the MT network. Periodical cross-linking of isolated MTs by recombinant TPPP/p25 were 
visualized by electron microscopy as well11. The electron microscopic images showed that the majority of MTs, 
25–26 nm in diameter, formed bundles consisting of dozens of MTs decorated by rows of tiny projections and 
dense particles with a periodicity of about 16 nm. Similar electron microscopic analysis provided evidence for 
the periodic crosslinking of MTs by the tetrameric phosphofructokinase derived by the MT-bound dimeric 
enzymes12,13.
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Role of TPPP /p25 segments in the dimer-derived MT bundling. Both the monomeric and dimeric 
TPPP/p25 bind to tubulin and MT inducing MT assembly, however, the polymerization potency of dimers seems 
to be higher; MT bundling activity is displayed by the dimers as illustrated in the tentative model. On the basis 
of our previous and present data, we have established a molecular model for the maturation of the bundled MT 
structure stabilized by TPPP/p25 dimers (Fig. 4).
Discussion
TPPP/p25 has been recognized as a MAP that displays two crucial features: i) it does not have a 3D structure, 
namely it is disordered2,6,14; ii) it is enriched in inclusions of the neurons and oligodendrocytes in the cases of 
Parkinson’s disease and multiple system atrophy, respectively15; although in normal brain it is expressed primarily 
in oligodendrocytes16,17. The mechanism by which TPPP/p25 contributes to toxicity in Parkinson’s disease is 
related to its interaction with α -synuclein; their pathological complex has been considered as a potential drug 
target5,15. The physiological role of TPPP/p25 manifests itself in the differentiation of the progenitor oligodendro-
cytes as demonstrated by siRNA technique and specific microRNA (mir206)17. The differentiated oligodendro-
cytes are the major constituents of the myelin sheath.
The commented and critique papers, however, focus exclusively on the nature of the association of TPPP/p25 
with the MT system. It has been well-documented earlier that TPPP/p25 promotes tubulin polymerization and 
the simultaneous bundling of the polymerized tubulin forms2 that stabilizes the intracellular MT ultrastructures 
such as perinuclear cage or aggresome10, and it makes them resistant against anti-microtubular agents such as 
nocodazole or vinblastine7,10. At cellular level bundling of the MT network by ectopically expressed TPPP/p25 in 
HeLa cells was demonstrated by both confocal and electron microscopies as well10, which revealed the existence 
of cross-linked MTs: the perinuclear cage consists of bundles of densely packed, parallel-aligned MTs running at 
different angles in close proximity to the nuclear membrane (cf. electron microscopic image).
Our experiments performed by immunofluorescent microscopy were reproduced by the Skoufias’ lab and pre-
sented in the DeBonis’ paper1 with references to our reported data. The single experiment that was not reproduced 
is the in vitro dimerization of the human recombinant TPPP/p25 in the absence of tubulin/MTs1. By studying care-
fully the differences of the experimental conditions used in the two labs we recognized a critical point causing the 
discrepancy, namely that all experiments performed in relation to the dimerization of TPPP/p25 by Skoufias and 
co-workers were carried out at reducing conditions (in the presence of DTT) that counteracted the stabilization of 
Figure 2. Tubulin polymerization and bundling potency of the TPPP/p25 forms as detected by 
turbidimetry (a,c) as well as by SDS/PAGE (b,d). (a) Tubulin assembly induced by the TPPP/p25 forms 
(turbidimetry); (b) pelleting of the assembled forms detected by SDS/PAGE in the presence of DTE; (c) cross-
linking of paclitaxel-stabilized MT by TPPP/p25 forms; (d) co-pelleting of the TPPP/p25 forms with paclitaxel-
stabilized MTs. Standard deviation (SD) was ± 10% (n = 3).
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Figure 3. Intracellular dimerization of TPPP/p25 and CORE pairs in HeLa cells as detected by BiFC assay. 
BiFC signals of the N- and C-segments of the mVenus BiFC constructs coupled with FL (a,d–f) or CORE 
TPPP/p25 pairs (b,g–i) or without them (empty mVenus BiFC vectors) (c) as detected by immunofluorescence 
microscopy. Co-localization of the BiFC signals of TPPP/p25 (f) with the MT network and its lack in the case of 
CORE variant (i) is shown; the MT network is stained with Alexa546 (e,h). Note that the BiFC signal is aligned 
along the bundled MT network in TPPP/p25 expressing cells, however, the CORE segment-derived signal 
distributes homogeneously within the intracellular space of HeLa cells. Nuclei were counterstained with DAPI. 
Scale bar: 10 μ m. BiFC signals were generated by co-transfection of the cells with the TPPP/p25 or CORE forms 
fused to mVenus BiFC constructs (a generous gift of Prof. Péter Várnai; Physiology Department, Semmelweis 
University, Budapest) according to the scheme (j).
www.nature.com/scientificreports/
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the dimers by disulphide bridges4. The spontaneous formation of the intermolecular covalent bridges at room tem-
perature above 10 μ M TPPP/p25 concentration can ensure the detection of dimers even by SDS/PAGE4. However, 
it is important to emphasize that TPPP/p25 dimers were detected in our lab, but not in Skoufias’s lab, by sandwich 
ELISA, isothermal titration calorimetry and size exclusion gel chromatography as well4,8.
In this paper we refer to a couple of data reported previously4,5,8; in addition, new sets of experiments have also 
been performed that allowed us to suggest a plausible mechanism for the role of the unstructured N- and C-termini 
of TPPP/p25 in the dimer-derived MT bundling. Our previous electron microscopic studies underlined that the 
MTs are cross-linked by TPPP/p25, formed bundles of 25–26 nm in diameter consisting of dozens of MTs deco-
rated by rows of tiny projections and dense particles with a periodicity of about 16 nm were observed2,11. In fact, the 
particles, likely dimers, express significant stabilization effect, similar to one as detected in the case of tau protein18. 
The tau protein, a key MAP of the brain MT system occurs in soluble form in normal neuronal cells, and the soluble 
tau-tau interactions display stabilizing effect as well on the MT structures19,20. The formation of the pathological tau 
filaments has been reported, the development of which are promoted by the presence of MTs19. No TPPP/p25 fila-
ment formations have been detected as indicated in a recent paper as well to our knowledge; however, the formation 
of α -synuclein filaments has been established at substoichiometric TPPP/p25 concentration21.
In conclusion, our previous and the new data presented in this comment paper support the role of TPPP/
p25 in the MT bundling in agreement with the title’s message of the Skoufias’s paper1 that focuses on the dimer-
ization potency of this disordered, brain-specific MAP2,4. This issue does not seem to be affected by differences 
manifesting in the truncation sites: the Skoufias’s group chose shorter CORE segment based on bioinformatics 
analysis1 than we had published originally on the basis of multinuclear magnetic resonance study6. Based upon 
our previous and present in vitro and in vivo data obtained with the FL and truncated TPPP/p25 forms, we have 
established a molecular model for the maturation of the bundled MT structure stabilized by TPPP/p25 dimers 
(Fig. 4). We do not exclude other possible mechanisms such as the binding of the N- and C- termini to separate 
MTs. Nevertheless, the key issue is the crucial role of the unstructured termini, not in the dimerization but in the 
cross-linking of MTs, in which all segments (CORE, N- and C-termini) are involved with distinct binding affinity 
in a cooperative manner. The TPPP/p25-derived stabilization of the MT network seems to be of physiological 
importance in the development of projections in the course of the differentiation of oligodendrocytes17.
We are grateful for Skoufias and his co-workers for their work on the TPPP/p25 project, in fact, the paper in 
the Scientific Reports1 was a challenge which inspired us to reconsider our data and carry out further experiments 
in order to suggest a molecular mechanism regarding the MT bundling by TPPP/p25.
Materials and Methods
Antibodies. The following antibodies were used: mouse monoclonal tubulin antibody (Sigma T9026, clone 
DM1A), mouse monoclonal TPPP/p25 antibody9 and rat polyclonal TPPP/p25 antibody15.
Figure 4. Tentative model for the development of the MT bundling in the course of dimerization of the TPPP/
p25. All components (CORE and N- or C- termini) bind to MTs, but with different affinities based on Figs 1 and 
2. Circular and semicircular forms represent dimeric and monomeric species, respectively; termini lines: back and 
red illustrate the N- and C-termini, respectively. The N- and C-termini could be positioned similarly or oppositely; 
however, the C-terminus binds with higher affinity as the N- one. The association of the C-terminal segment seems 
to be determining in the bundling process coupled without or with conformational changes.
www.nature.com/scientificreports/
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Tubulin preparation. Tubulin was prepared from bovine brain according to the method of Na and Timasheff22.
Expression and purification of human recombinant wild type and mutant TPPP/p25 forms. 
Human recombinant TPPP/p25 forms and fragments possessing His-tags were expressed in E. coli BL21 (DE3) 
cells and isolated on HIS-Select™ Cartridge (Sigma-Aldrich) as described previously5,15. The purity of proteins 
was analysed by SDS-PAGE. Protein concentrations of the TPPP/p25 variants were determined on the basis 
of the absorbance at 280 nm using the extinction coefficients evaluated by ProtParam (http://web.expasy.org/
protparam/), 10095 M−1 *cm−1 for FL TPPP/p25 and N-terminal truncated TPPP/p25; 5625 M−1 *cm−1 for 
C-terminal truncated TPPP/p25 and CORE, respectively.
BiFC plasmids. The BiFC plasmids (pBiFC-VN1-173, pBiFC-VC155-238) were the gift of Prof. Péter Várnai 
(Semmelweis University, Budapest). To insert the FL TPPP/p25 cDNA in either the pBiFC-VN1-173 or pBiFC- 
VC155-238 the following primers for polymerase chain reaction (PCR) amplification were used: for-
ward 5-GAAGGAGCTCGAGATATGGCTGACAAGGCTAAGC-3 and reverse 5-CCGTGGATCC 
CTACTTGCCCCCTTGCACCTTCTGGTCGTAGG-3 and pET21c-TPPP/p25 as a template. The PCR 
product, following purification and after digestion with XhoI-BamHI restriction enzymes, was inserted 
to XhoI and BamHI sites in the BiFC vectors. To insert the CORE segment of TPPP/p25 (TPPP/p25 delta 
3–43/delta 175–219) cDNA in either the pBiFC-VN1-173 or pBiFC-VC155-238, the following primers 
for PCR amplification were used: forward 5- GGAATTC TATGGCTGCATCCCCTGAG-3 and reverse 
5- ATGGATCCCTAGCCCGTGAACTTGGT-3′ and pET21c-TPPP/p25 as a template. The PCR product, follow-
ing purification and after digestion with EcoRI-BamHI restriction enzymes, was inserted to EcoRI and BamHI 
sites in the BiFC vectors. The sequences of all construct were verified by restriction mapping and sequencing.
ELISA. Sandwich ELISA assays were carried out similarly as described previously8. The plate was coated with 1 μ g/mL 
(50 μ L/well) mAb9 in 200 mM Na2CO3 buffer pH 9.6 overnight at 4 °C. The wells were blocked with 1 mg/mL 
bovine serum albumin in phosphate-buffered saline (PBS) for 1 h at room temperature. Next, the plate was incu-
bated with serial dilutions of 5 μ M TPPP/p25 for 1 h at room temperature in PBS. Where indicated, TPPP/p25 
was pre-incubated with 100 μ M DTE for 30 min at room temperature. In another experimental setup, different 
TPPP forms at 1 μ M concentration were added to the plate coated with mAb in the absence and presence of DTE. 
Alternatively, 1 μ M FL TPPP/p25 or CORE TPPP/p25 was preincubated with 100 μ M DTE for 30 min at room 
temperature, then added to the plate coated with mAb; after removing the excess DTE, the different TPPP/p25 
forms were added, and dimers were detected by biotinylated mAb. Then the plate was sequentially incubated with 
biotinylated mAb (1 μ g/mL) and peroxidase conjugated avidin (Calbiochem) (2.5 μ g/mL). Both antibodies were 
in PBS buffer containing 1 mg/mL bovine serum albumin, and incubated for 1 h at room temperature. Between 
each incubation step the wells were washed thrice with PBS containing 0.05% Tween 20 for 10 min. The presence 
of antibodies was detected using o-phenylenediamine as substrate. The reaction was stopped after 10 min with 
1 M H2SO4, and the absorbance was read at 490 nm with an EnSpire Multimode Reader (Perkin Elmer). The bind-
ing constants (Kd) were evaluated from the saturation curves by non-linear curve fitting assuming single binding 
site hyperbola model using the Origin 8.0 software.
Turbidity measurements. The assembly of tubulin (7 μ M) was assessed in polymerization buffer (50 mM 
2-(N-morpholino) ethanesulfonic acid buffer pH 6.6 containing 100 mM KCl, 1 mM DTE, 1 mM MgCl2 and 
1 mM ethylene glycol tetraacetic acid) at 37 °C. The tubulin polymerization into MTs was induced by the addition 
of 3 μ M of the different TPPP/p25 forms. In another set of experiments, the polymerization of 10 μ M tubulin into 
MTs was induced by the addition of 20 μ M paclitaxel then subsequently 3 μ M TPPP/p25 proteins were added to 
the solution. The optical density was monitored at 350 nm by a Cary 100 spectrophotometer (Varian).
Pelleting experiments. Tubulin (5 μ M) was incubated with the different TPPP/p25 forms (10 μ M) for 
10 min at 37 °C in polymerization buffer. In another set of experiments, 10 μ M paclitaxel-stabilized MTs was 
incubated with the different TPPP/p25 forms (10 μ M) for 10 min at 37 °C in polymerization buffer. After cen-
trifugation at 17000 g for 15 min at 37 °C, the pellet and the supernatant fractions were separated. The pellet 
fraction was washed and resuspended in buffer. Then the fractions containing 2-mercaptoethanol were analysed 
by SDS-PAGE, separated on a 13.5% gel and stained with Coomassie Brilliant Blue R-250.
Cell culture, transfection and manipulation. HeLa cells (ATCC® CCL-2™ , American Type Culture 
Collection) were grown in Dulbecco’s modified eagle medium supplemented with 10% fetal calf serum and 100 μ g/ml 
kanamycin in a humidified incubator at 37 °C with 5% CO2. Cells were grown on 12-mm-diameter glass cov-
erslips for microscopic analysis. For the evaluation of the BiFC signal, HeLa cells were transfected with differ-
ent mVenus constructs of TPPP/p25 (0.3 μ g of each plasmid) using Turbofect (Invitrogen) transfection reagent 
according to the manufacture’s protocol. Monoclonal tubulin antibody (Sigma T9026) and an Alexa 546 conju-
gated mouse secondary antibody (Thermo Fisher Scientific A11030) were used for the detection of the tubulin 
signal. Nuclei were counterstained with 4′ ,6-diamidino-2-phenylindole (DAPI). Images of the mounted samples 
were acquired on a Leica DM IL 500 microscope equipped with Leica DFC 395 FX camera and HBO 100w lamp. 
The equipment software was Leica Application Suite 4.4.0. Chroma UV filter set (No. C40888), Chroma 41028 
HQ NB GFP filter set (No. C21116) and Leica filter N2.1 (No. 513832) was used for DAPI, BiFC and Alexa 546 
signal acquisition, respectively, using a HCX FL Fluotar 40x/0.75 (dry) objective.
Statistics. Each data point represents the mean ± standard deviation (SD) from three independent experiments.
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